Sequential loss of alleles encoding p16 has been proposed to contribute to the progression from normal melanocytes to malignant melanoma via benign nevi, dysplastic nevi, radial growth phase (RGP), and vertical growth phase (VGP) stages (Bennett, 2008, Ha et al., 2008). Here, CDKN2A is linked to melanoma.